Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Summary by SnackSafely.com
Aquestive resubmits its Anaphylm NDA after completing additional human factors and pharmacokinetic studies requested by the FDA.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

Allergic LivingAllergic Living

Anaphylm Epi Film Heads Back to FDA for Approval Review

Aquestive Therapeutics has resubmitted its under-the-tongue epinephrine film to the Food and Drug Administration to be considered for approval.  ... Read more »

Read Full Article
SnackSafely.comSnackSafely.com

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Aquestive resubmits its Anaphylm NDA after completing additional human factors and pharmacokinetic studies requested by the FDA.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

SnackSafely.com broke the news on Thursday, September 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal